SIBP-A16 buffer solution: Clinical Trials

2 trials of SIBP-A16 buffer solution, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow SIBP-A16 buffer solution: new trials by email Literature Review of SIBP-A16 buffer solution trials Research Report on SIBP-A16 buffer solution

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants
SIBP-A16 injection, Nirsevimab, SIBP-A16 buffer solution - Respiratory Syncytial Virus (RSV)
Phase 1 / Phase 2Not yet recruitingShanghai Institute Of Biological Products362026-01-152026-01-23
A Clinical Trial of SIBP-A16 Injection in Healthy Adults
SIBP-A16 injection, Nirsevimab, SIBP-A16 buffer solution - Respiratory Syncytial Virus (RSV)
Early Phase 1RecruitingShanghai Institute Of Biological Products1402025-08-172025-11-25

Conditions studied

Premature Birth (1)

Sponsors

Shanghai Institute Of Biological Products (2)

Countries

China (2)

Top investigators

Hanwen Liu (1)